Anti-Obesity Drugs Market: Trends, Growth Drivers, and Future Prospects (2024 – 2032)

Obesity is a global health crisis, contributing to numerous chronic conditions such as diabetes, cardiovascular diseases, and certain cancers. As a result, the demand for effective anti-obesity drugs is rising. In 2023, the global anti-obesity drugs market was valued at USD 2.5 billion, with the Asia Pacific region holding a significant market share. The market is driven by the increasing prevalence of obesity and is expected to grow at a compound annual growth rate (CAGR) of 10.70% during the forecast period of 2024-2032, reaching USD 6.3 billion by 2032. This article explores the factors driving this growth, key market trends, challenges, and future opportunities in the anti-obesity drugs market.